A Phase I/II Study of CC-4047 [pamolidomide] in Combination With Gemcitabine in Subjects With Untreated Advanced Carcinoma of the Pancreas.
Phase of Trial: Phase I/II
Latest Information Update: 24 Nov 2013
At a glance
- Drugs Pomalidomide (Primary) ; Gemcitabine
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 02 May 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 02 May 2011 Actual end date (Jan 2011) added as reported by ClinicalTrials.gov.
- 20 Jan 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.